Drugs Approved for Childhood Cancers
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for use in children. The list includes generic and brand names. The drug names link to NCI's Cancer Drug Information summaries. There are drugs and drug combinations used to treat children with cancer that are not listed here.
Drugs Approved for Alveolar Soft Part Sarcoma
Drugs Approved for Colorectal Cancer
Drugs Approved for Epithelioid Sarcoma
Drugs Approved for Ewing Sarcoma
Drugs Approved for Gestational Trophoblastic Disease
Drugs Approved for Giant Cell Astrocytoma
Drugs Approved for Glioma
Drugs Approved for Hodgkin Lymphoma
Drugs Approved for Leukemia
Drugs Approved for Acute Lymphoblastic Leukemia (ALL)
- Asparaginase Erwinia Chrysanthemi (Erwinaze)
- Asparaginase Erwinia Chrysanthemi (Recombinant)-rywn (Rylaze)
- Blinatumomab (Blincyto)
- Calaspargase Pegol-mknl (Asparlas)
- Clofarabine (Clolar)
- Cyclophosphamide
- Cytarabine
- Dasatinib (Sprycel)
- Daunorubicin Hydrochloride
- Imatinib Mesylate (Gleevec)
- Mercaptopurine (Purinethol, Purixan)
- Methotrexate Sodium (Trexall)
- Nelarabine (Arranon)
- Pegaspargase (Oncaspar)
- Revumenib Citrate (Revuforj)
- Rituximab (Rituxan)
- Tisagenlecleucel (Kymriah)
- Vincristine Sulfate
Drugs Approved for Acute Myeloid Leukemia (AML)
Drugs Approved for Blastic Plasmacytoid Dendritic Cell Neoplasm
Drugs Approved for Chronic Myelogenous Leukemia (CML)
Drugs Approved for Juvenile Myelomonocytic Leukemia (JMML)
Drugs Approved for Melanoma
Drugs Approved for Merkel Cell Carcinoma
Drugs Approved for Neuroblastoma
Drugs Approved for Neurofibromatosis Type 1
Drugs Approved for Non-Hodgkin Lymphoma
Drugs Approved for Pheochromocytoma and Paraganglioma
Drugs Approved for Rhabdomyosarcoma
Drugs Approved for Solid Tumors Anywhere in the Body
Drugs Approved for Thyroid Cancer
Drugs Approved for Wilms Tumor and Other Childhood Kidney Cancers